Zacks Investment Research on MSN
Insights Into DexCom (DXCM) Q3: Wall Street Projections for Key Metrics
The upcoming report from DexCom (DXCM) is expected to reveal quarterly earnings of $0.57 per share, indicating an increase of 26.7% compared to the year-ago period. Analysts forecast revenues of $1.18 ...
Dexcom faces new FDA reports linking its G7 glucose monitor to patient deaths as lawsuits and regulatory scrutiny intensify.
Zacks Investment Research on MSN
Can Dexcom Deliver Strong Q3 Earnings on Stelo Gains and G7 Adoption?
DexCom, Inc. DXCM is scheduled to report third-quarter 2025 resultson Oct. 30, after the closing bell. In the last reported ...
DANVILLE, CA, UNITED STATES, April 13, 2023/EINPresswire.com/ -- GenieMD, Inc. (“GenieMD”), a leader in virtual care platform and services, recognized by Frost ...
After plenty of anticipation — and a bit of waiting — the next-generation Dexcom G7 continuous glucose monitor is finally here. In mid-2021, Dexcom (Nasdaq:DXCM) CEO Kevin Sayer told Drug Delivery ...
The Australian government has expanded the subsidised access to the latest generation of Dexcom's continuous glucose monitoring device, Dexcom G6, for diabetic Australians. This comes as the previous ...
ATLANTA — When Julie Tuttle watched the 2021 Superbowl from her living room between the Tampa Bay Buccaneers and the Kansas City Chiefs, she nearly turned the television off. However, it wasn't the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results